nodes	percent_of_prediction	percent_of_DWPC	metapath
Afatinib—ERBB4—forebrain—attention deficit hyperactivity disorder	0.0324	0.05	CbGeAlD
Afatinib—DYRK1A—forebrain—attention deficit hyperactivity disorder	0.0311	0.0481	CbGeAlD
Afatinib—ERBB4—cardiovascular system—attention deficit hyperactivity disorder	0.0274	0.0423	CbGeAlD
Afatinib—ERBB2—cardiovascular system—attention deficit hyperactivity disorder	0.0274	0.0423	CbGeAlD
Afatinib—DYRK1A—cardiovascular system—attention deficit hyperactivity disorder	0.0263	0.0407	CbGeAlD
Afatinib—ERBB4—midbrain—attention deficit hyperactivity disorder	0.0214	0.033	CbGeAlD
Afatinib—EPHA6—nervous system—attention deficit hyperactivity disorder	0.0203	0.0313	CbGeAlD
Afatinib—HIPK4—brain—attention deficit hyperactivity disorder	0.0196	0.0303	CbGeAlD
Afatinib—PHKG2—nervous system—attention deficit hyperactivity disorder	0.0195	0.0302	CbGeAlD
Afatinib—EPHA6—central nervous system—attention deficit hyperactivity disorder	0.0195	0.0301	CbGeAlD
Afatinib—PHKG2—central nervous system—attention deficit hyperactivity disorder	0.0188	0.0291	CbGeAlD
Afatinib—PHKG2—cerebellum—attention deficit hyperactivity disorder	0.0184	0.0284	CbGeAlD
Afatinib—ERBB2—nervous system—attention deficit hyperactivity disorder	0.0176	0.0271	CbGeAlD
Afatinib—ERBB4—nervous system—attention deficit hyperactivity disorder	0.0176	0.0271	CbGeAlD
Afatinib—ERBB2—central nervous system—attention deficit hyperactivity disorder	0.0169	0.0261	CbGeAlD
Afatinib—ERBB4—central nervous system—attention deficit hyperactivity disorder	0.0169	0.0261	CbGeAlD
Afatinib—DYRK1A—nervous system—attention deficit hyperactivity disorder	0.0169	0.0261	CbGeAlD
Afatinib—ERBB2—cerebellum—attention deficit hyperactivity disorder	0.0165	0.0255	CbGeAlD
Afatinib—ERBB4—cerebellum—attention deficit hyperactivity disorder	0.0165	0.0255	CbGeAlD
Afatinib—DYRK1A—central nervous system—attention deficit hyperactivity disorder	0.0163	0.0252	CbGeAlD
Afatinib—IRAK1—midbrain—attention deficit hyperactivity disorder	0.016	0.0247	CbGeAlD
Afatinib—DYRK1A—cerebellum—attention deficit hyperactivity disorder	0.0159	0.0246	CbGeAlD
Afatinib—EPHA6—brain—attention deficit hyperactivity disorder	0.0155	0.0239	CbGeAlD
Afatinib—PHKG2—brain—attention deficit hyperactivity disorder	0.0149	0.0231	CbGeAlD
Afatinib—EGFR—cerebellum—attention deficit hyperactivity disorder	0.014	0.0217	CbGeAlD
Afatinib—ERBB2—brain—attention deficit hyperactivity disorder	0.0134	0.0208	CbGeAlD
Afatinib—ERBB4—brain—attention deficit hyperactivity disorder	0.0134	0.0208	CbGeAlD
Afatinib—DYRK1A—brain—attention deficit hyperactivity disorder	0.0129	0.02	CbGeAlD
Afatinib—IRAK1—cerebellum—attention deficit hyperactivity disorder	0.0124	0.0191	CbGeAlD
Afatinib—ABL1—cardiovascular system—attention deficit hyperactivity disorder	0.0115	0.0177	CbGeAlD
Afatinib—EGFR—brain—attention deficit hyperactivity disorder	0.0114	0.0176	CbGeAlD
Afatinib—IRAK1—brain—attention deficit hyperactivity disorder	0.01	0.0155	CbGeAlD
Afatinib—ABL1—midbrain—attention deficit hyperactivity disorder	0.00895	0.0138	CbGeAlD
Afatinib—ABL1—nervous system—attention deficit hyperactivity disorder	0.00736	0.0114	CbGeAlD
Afatinib—ABL1—central nervous system—attention deficit hyperactivity disorder	0.00709	0.011	CbGeAlD
Afatinib—ABL1—cerebellum—attention deficit hyperactivity disorder	0.00693	0.0107	CbGeAlD
Afatinib—ABCG2—midbrain—attention deficit hyperactivity disorder	0.00565	0.00873	CbGeAlD
Afatinib—ABL1—brain—attention deficit hyperactivity disorder	0.00563	0.00869	CbGeAlD
Afatinib—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.00437	0.00675	CbGeAlD
Afatinib—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00422	0.00652	CbGeAlD
Afatinib—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00356	0.00551	CbGeAlD
Afatinib—ABCG2—brain—attention deficit hyperactivity disorder	0.00355	0.00548	CbGeAlD
Afatinib—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00278	0.0043	CbGeAlD
Afatinib—EGFR—SHP2 signaling—BDNF—attention deficit hyperactivity disorder	0.0024	0.0068	CbGpPWpGaD
Afatinib—ERBB2—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.00237	0.00672	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.00234	0.00662	CbGpPWpGaD
Afatinib—LCK—SHP2 signaling—BDNF—attention deficit hyperactivity disorder	0.00231	0.00656	CbGpPWpGaD
Afatinib—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00229	0.00354	CbGeAlD
Afatinib—ERBB2—Adaptive Immune System—STUB1—attention deficit hyperactivity disorder	0.00221	0.00625	CbGpPWpGaD
Afatinib—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.0022	0.00341	CbGeAlD
Afatinib—ERBB2—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00219	0.0062	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—STUB1—attention deficit hyperactivity disorder	0.00217	0.00615	CbGpPWpGaD
Afatinib—ERBB2—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00216	0.00612	CbGpPWpGaD
Afatinib—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00215	0.00333	CbGeAlD
Afatinib—BLK—Adaptive Immune System—STUB1—attention deficit hyperactivity disorder	0.00209	0.00592	CbGpPWpGaD
Afatinib—EPHA6—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00208	0.0059	CbGpPWpGaD
Afatinib—ERBB2—Validated targets of C-MYC transcriptional repression—EP300—attention deficit hyperactivity disorder	0.00208	0.0059	CbGpPWpGaD
Afatinib—LCK—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.00198	0.00561	CbGpPWpGaD
Afatinib—ERBB2—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00198	0.0056	CbGpPWpGaD
Afatinib—ERBB2—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00191	0.00542	CbGpPWpGaD
Afatinib—EPHA6—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00191	0.0054	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00179	0.00508	CbGpPWpGaD
Afatinib—ABCB1—brain—attention deficit hyperactivity disorder	0.00175	0.0027	CbGeAlD
Afatinib—ERBB2—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.00174	0.00493	CbGpPWpGaD
Afatinib—ABL1—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00174	0.00492	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.00171	0.00486	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.00171	0.00486	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways in Glioblastoma—EP300—attention deficit hyperactivity disorder	0.00169	0.00477	CbGpPWpGaD
Afatinib—DYRK1A—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.00166	0.0047	CbGpPWpGaD
Afatinib—EGFR—Signaling by NGF—RTN4—attention deficit hyperactivity disorder	0.00161	0.00455	CbGpPWpGaD
Afatinib—LCK—Signaling by NGF—RTN4—attention deficit hyperactivity disorder	0.00155	0.00439	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00154	0.00437	CbGpPWpGaD
Afatinib—ABCG2—HIF-2-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00154	0.00436	CbGpPWpGaD
Afatinib—EGFR—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00148	0.0042	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00141	0.004	CbGpPWpGaD
Afatinib—ERBB2—Immune System—MB21D1—attention deficit hyperactivity disorder	0.00138	0.00391	CbGpPWpGaD
Afatinib—EGFR—Spinal Cord Injury—BDNF—attention deficit hyperactivity disorder	0.00136	0.00385	CbGpPWpGaD
Afatinib—ERBB4—Immune System—MB21D1—attention deficit hyperactivity disorder	0.00136	0.00385	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.00134	0.0038	CbGpPWpGaD
Afatinib—ERBB2—Immune System—STUB1—attention deficit hyperactivity disorder	0.00134	0.00379	CbGpPWpGaD
Afatinib—ABL1—Validated transcriptional targets of TAp63 isoforms—EP300—attention deficit hyperactivity disorder	0.00133	0.00377	CbGpPWpGaD
Afatinib—ERBB4—Immune System—STUB1—attention deficit hyperactivity disorder	0.00132	0.00373	CbGpPWpGaD
Afatinib—BLK—Immune System—MB21D1—attention deficit hyperactivity disorder	0.00131	0.00371	CbGpPWpGaD
Afatinib—EGFR—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.00129	0.00367	CbGpPWpGaD
Afatinib—EGFR—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.00129	0.00367	CbGpPWpGaD
Afatinib—BLK—Immune System—STUB1—attention deficit hyperactivity disorder	0.00127	0.00359	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.00126	0.00356	CbGpPWpGaD
Afatinib—ABL1—p53 pathway—EP300—attention deficit hyperactivity disorder	0.00124	0.00352	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00124	0.00351	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00124	0.00351	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00124	0.0035	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00124	0.0035	CbGpPWpGaD
Afatinib—ERBB2—Disease—STUB1—attention deficit hyperactivity disorder	0.00123	0.0035	CbGpPWpGaD
Afatinib—ABL1—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00122	0.00346	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00122	0.00345	CbGpPWpGaD
Afatinib—ERBB4—Disease—STUB1—attention deficit hyperactivity disorder	0.00122	0.00345	CbGpPWpGaD
Afatinib—ABCG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00121	0.00343	CbGpPWpGaD
Afatinib—PHKG2—Disease—SNAP25—attention deficit hyperactivity disorder	0.00118	0.00335	CbGpPWpGaD
Afatinib—ABCG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00115	0.00327	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.00115	0.00325	CbGpPWpGaD
Afatinib—ABL1—Regulation of retinoblastoma protein—EP300—attention deficit hyperactivity disorder	0.00113	0.00321	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00113	0.00321	CbGpPWpGaD
Afatinib—ABL1—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00112	0.00317	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00111	0.00314	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.0011	0.00313	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00109	0.00309	CbGpPWpGaD
Afatinib—ABL1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00108	0.00307	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—STUB1—attention deficit hyperactivity disorder	0.00107	0.00302	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00106	0.003	CbGpPWpGaD
Afatinib—EGFR—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00104	0.00296	CbGpPWpGaD
Afatinib—LCK—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.00104	0.00295	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—STUB1—attention deficit hyperactivity disorder	0.00103	0.00291	CbGpPWpGaD
Afatinib—EGFR—MAPK Signaling Pathway—BDNF—attention deficit hyperactivity disorder	0.00103	0.00291	CbGpPWpGaD
Afatinib—LCK—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00102	0.00289	CbGpPWpGaD
Afatinib—ERBB2—Immune System—POLR3A—attention deficit hyperactivity disorder	0.00101	0.00287	CbGpPWpGaD
Afatinib—ERBB4—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000999	0.00283	CbGpPWpGaD
Afatinib—IRAK1—Immune System—MB21D1—attention deficit hyperactivity disorder	0.000999	0.00283	CbGpPWpGaD
Afatinib—LCK—Notch Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.000995	0.00282	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000989	0.0028	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.000985	0.00279	CbGpPWpGaD
Afatinib—ABL1—p73 transcription factor network—EP300—attention deficit hyperactivity disorder	0.000982	0.00278	CbGpPWpGaD
Afatinib—IRAK1—Immune System—STUB1—attention deficit hyperactivity disorder	0.000967	0.00274	CbGpPWpGaD
Afatinib—BLK—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000961	0.00272	CbGpPWpGaD
Afatinib—EGFR—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.000956	0.00271	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000941	0.00267	CbGpPWpGaD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000925	0.00262	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000907	0.00257	CbGpPWpGaD
Afatinib—ABCG2—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000905	0.00256	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.000872	0.00247	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000865	0.00245	CbGpPWpGaD
Afatinib—ERBB2—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000857	0.00243	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000852	0.00241	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.000841	0.00238	CbGpPWpGaD
Afatinib—DYRK1A—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.000837	0.00237	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways in Glioblastoma—EP300—attention deficit hyperactivity disorder	0.000815	0.00231	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.000811	0.0023	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000801	0.00227	CbGpPWpGaD
Afatinib—ABL1—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000801	0.00227	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.000798	0.00226	CbGpPWpGaD
Afatinib—ABL1—Immune System—MB21D1—attention deficit hyperactivity disorder	0.000781	0.00221	CbGpPWpGaD
Afatinib—EGFR—Androgen receptor signaling pathway—EP300—attention deficit hyperactivity disorder	0.000763	0.00216	CbGpPWpGaD
Afatinib—ABL1—Immune System—STUB1—attention deficit hyperactivity disorder	0.000757	0.00214	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—COMT—attention deficit hyperactivity disorder	0.00075	0.00212	CbGpPWpGaD
Afatinib—DYRK1A—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000748	0.00212	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.000746	0.00211	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000744	0.00211	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000743	0.0021	CbGpPWpGaD
Afatinib—IRAK1—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000733	0.00208	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000732	0.00207	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000728	0.00206	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000717	0.00203	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000714	0.00202	CbGpPWpGaD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000711	0.00201	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000703	0.00199	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.000682	0.00193	CbGpPWpGaD
Afatinib—EGFR—Immune System—MB21D1—attention deficit hyperactivity disorder	0.000668	0.00189	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000654	0.00185	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000651	0.00185	CbGpPWpGaD
Afatinib—EGFR—Immune System—STUB1—attention deficit hyperactivity disorder	0.000647	0.00183	CbGpPWpGaD
Afatinib—LCK—Immune System—MB21D1—attention deficit hyperactivity disorder	0.000643	0.00182	CbGpPWpGaD
Afatinib—ABL1—Factors involved in megakaryocyte development and platelet production—EP300—attention deficit hyperactivity disorder	0.000636	0.0018	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000625	0.00177	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000624	0.00177	CbGpPWpGaD
Afatinib—LCK—Immune System—STUB1—attention deficit hyperactivity disorder	0.000623	0.00177	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000608	0.00172	CbGpPWpGaD
Afatinib—EGFR—Disease—STUB1—attention deficit hyperactivity disorder	0.000597	0.00169	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000596	0.00169	CbGpPWpGaD
Afatinib—ERBB2—Disease—SNAP25—attention deficit hyperactivity disorder	0.000585	0.00166	CbGpPWpGaD
Afatinib—ABL1—Integrated Breast Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000585	0.00166	CbGpPWpGaD
Afatinib—ERBB4—Disease—SNAP25—attention deficit hyperactivity disorder	0.000577	0.00163	CbGpPWpGaD
Afatinib—LCK—Disease—STUB1—attention deficit hyperactivity disorder	0.000575	0.00163	CbGpPWpGaD
Afatinib—ABL1—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000574	0.00162	CbGpPWpGaD
Afatinib—EPHA6—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000541	0.00153	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000537	0.00152	CbGpPWpGaD
Afatinib—LCK—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000536	0.00152	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000536	0.00152	CbGpPWpGaD
Afatinib—EGFR—Direct p53 effectors—EP300—attention deficit hyperactivity disorder	0.000531	0.0015	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000526	0.00149	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000516	0.00146	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000516	0.00146	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000505	0.00143	CbGpPWpGaD
Afatinib—EGFR—Integrated Breast Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.0005	0.00142	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000497	0.00141	CbGpPWpGaD
Afatinib—EGFR—Immune System—POLR3A—attention deficit hyperactivity disorder	0.00049	0.00139	CbGpPWpGaD
Afatinib—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000489	0.00139	CbGpPWpGaD
Afatinib—ABL1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000485	0.00137	CbGpPWpGaD
Afatinib—LCK—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000472	0.00134	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000467	0.00132	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000441	0.00125	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000434	0.00123	CbGpPWpGaD
Afatinib—ABCG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000421	0.00119	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000418	0.00118	CbGpPWpGaD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000414	0.00117	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000413	0.00117	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00041	0.00116	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000404	0.00114	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000403	0.00114	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000401	0.00114	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000401	0.00114	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000397	0.00112	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000391	0.00111	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00039	0.00111	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000385	0.00109	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000384	0.00109	CbGpPWpGaD
Afatinib—PHKG2—Disease—EP300—attention deficit hyperactivity disorder	0.000384	0.00109	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00038	0.00108	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000365	0.00103	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000361	0.00102	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000359	0.00102	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000359	0.00102	CbGpPWpGaD
Afatinib—ERBB2—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000354	0.001	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000354	0.001	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000352	0.000997	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000349	0.000987	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000346	0.000981	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000345	0.000978	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000339	0.000961	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000336	0.000951	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000333	0.000942	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000325	0.000921	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000321	0.000911	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000319	0.000905	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000319	0.000903	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000315	0.000894	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000296	0.00084	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000294	0.000833	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000287	0.000813	CbGpPWpGaD
Afatinib—EGFR—Disease—SNAP25—attention deficit hyperactivity disorder	0.000283	0.000802	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000282	0.000799	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000279	0.00079	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000277	0.000784	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000277	0.000784	CbGpPWpGaD
Afatinib—LCK—Disease—SNAP25—attention deficit hyperactivity disorder	0.000273	0.000773	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000272	0.000771	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00026	0.000735	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000256	0.000725	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000253	0.000717	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000252	0.000712	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000248	0.000702	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000244	0.000691	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000235	0.000666	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000228	0.000645	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000227	0.000642	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000222	0.00063	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000221	0.000627	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000217	0.000614	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000213	0.000604	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000211	0.000597	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000209	0.000592	CbGpPWpGaD
Afatinib—ERBB2—Immune System—EP300—attention deficit hyperactivity disorder	0.000206	0.000584	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000206	0.000583	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000205	0.000582	CbGpPWpGaD
Afatinib—ERBB4—Immune System—EP300—attention deficit hyperactivity disorder	0.000203	0.000575	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.0002	0.000567	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000198	0.000562	CbGpPWpGaD
Afatinib—BLK—Immune System—EP300—attention deficit hyperactivity disorder	0.000195	0.000553	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000194	0.000549	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000192	0.000544	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000191	0.000541	CbGpPWpGaD
Afatinib—ERBB2—Disease—EP300—attention deficit hyperactivity disorder	0.00019	0.000539	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000189	0.000535	CbGpPWpGaD
Afatinib—ERBB4—Disease—EP300—attention deficit hyperactivity disorder	0.000187	0.000531	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000186	0.000528	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000185	0.000524	CbGpPWpGaD
Afatinib—LCK—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000183	0.000519	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000182	0.000515	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000182	0.000515	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00018	0.000509	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000174	0.000492	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000171	0.000485	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000168	0.000475	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000167	0.000474	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000167	0.000472	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000165	0.000467	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00015	0.000424	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00015	0.000424	CbGpPWpGaD
Afatinib—IRAK1—Immune System—EP300—attention deficit hyperactivity disorder	0.000149	0.000422	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000147	0.000417	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000137	0.000388	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000133	0.000377	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000131	0.000372	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000122	0.000344	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00012	0.000339	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000117	0.000332	CbGpPWpGaD
Afatinib—ABL1—Immune System—EP300—attention deficit hyperactivity disorder	0.000117	0.00033	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000114	0.000323	CbGpPWpGaD
Afatinib—EGFR—Immune System—EP300—attention deficit hyperactivity disorder	9.96e-05	0.000282	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	9.63e-05	0.000273	CbGpPWpGaD
Afatinib—LCK—Immune System—EP300—attention deficit hyperactivity disorder	9.6e-05	0.000272	CbGpPWpGaD
Afatinib—EGFR—Disease—EP300—attention deficit hyperactivity disorder	9.2e-05	0.000261	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	9.07e-05	0.000257	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	9e-05	0.000255	CbGpPWpGaD
Afatinib—LCK—Disease—EP300—attention deficit hyperactivity disorder	8.87e-05	0.000251	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	7.19e-05	0.000204	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.44e-05	0.000182	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.21e-05	0.000176	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	3.89e-05	0.00011	CbGpPWpGaD
